The idea that depression is caused by a “chemical imbalance” in the brain is not supported by scientific evidence. A major 2022 umbrella review published in Molecular Psychiatry examined decades of serotonin research and found no consistent evidence that low serotonin levels cause depression. But the full picture is more nuanced than “it’s a myth.” Depression is a real biological condition. The problem isn’t that brain chemistry plays no role; it’s that the “chemical imbalance” framing was always a dramatic oversimplification of something far more complex.
Where the Idea Came From
The serotonin hypothesis of depression was first proposed in 1967 by British psychiatrist Alec Coppen. The reasoning was largely indirect: new antidepressant drugs had been shown in animal studies to boost serotonin activity at nerve connections in the brain. If drugs that increased serotonin seemed to relieve depression, the thinking went, then depression must be caused by too little serotonin. It was a logical guess, but it worked backward from a treatment effect to an assumed cause, which is a bit like concluding that headaches are caused by an aspirin deficiency.
Pharmaceutical marketing in the 1990s turned this hypothesis into a household explanation. As SSRIs became blockbuster drugs, the phrase “chemical imbalance” entered everyday language. It was memorable, easy to understand, and helped reduce the stigma of seeking treatment. But it was never a proven scientific fact. Even Coppen’s original 1967 paper mentioned other possible contributors, including stress hormones and the role of other brain chemicals beyond serotonin.
What the Evidence Actually Shows
The most comprehensive evaluation of the serotonin hypothesis came from Joanna Moncrieff and colleagues at University College London. Their 2022 umbrella review pulled together data from multiple meta-analyses covering thousands of participants. Two meta-analyses examining a serotonin byproduct in spinal fluid (the largest including over 1,000 people) found no association with depression. A separate meta-analysis of serotonin levels in blood plasma, covering nearly 1,900 people, also found no relationship. In fact, the only link between low serotonin and depression appeared in people already taking antidepressants, suggesting the drugs themselves were lowering baseline serotonin levels rather than correcting a pre-existing deficit.
The review’s conclusion was blunt: the main areas of serotonin research provide no consistent evidence of an association between serotonin and depression, and no support for the idea that depression is caused by lowered serotonin activity or concentrations.
What’s Actually Happening in the Brain
Depression does involve real, measurable changes in the brain. They’re just not as simple as “too little of one chemical.” Research shows that depression is linked to physical shrinkage of nerve cells in brain regions that control mood and emotion. Neurons lose branches and connections, supporting cells shrink in both size and number, and the communication networks between different brain areas weaken. The severity of these structural changes correlates with the severity of symptoms.
Chronic stress drives many of these changes. Prolonged exposure to stress hormones can alter how genes are expressed, sometimes creating lasting shifts in how the brain responds to future stress. These changes can affect neurotransmitter activity, immune signaling, hormone regulation, and the brain’s ability to form new connections, all at once. That’s a far cry from one chemical being too low.
Inflammation has emerged as another significant piece of the puzzle. People with major depression consistently show elevated markers of immune system activation in their blood, even when they’re otherwise physically healthy. These inflammatory signals can cross into the brain and disrupt the same systems involved in mood regulation, stress responses, and the brain’s ability to adapt and rewire. When certain patients receive immune-boosting drugs for other medical conditions, up to 50% of them develop depression as a side effect, which is some of the strongest evidence that inflammation can directly trigger depressive symptoms.
How Antidepressants Work (If Not by Fixing an Imbalance)
SSRIs do increase serotonin availability in the brain within hours. But their mood-lifting effects typically take weeks to appear. That delay is one of the strongest clues that boosting serotonin isn’t the real mechanism of relief. Instead, the downstream effects seem to matter more. Over time, antidepressants promote the growth of new neurons in the hippocampus, a brain region critical for mood and memory. They also strengthen the communication networks between different brain areas, and these connectivity improvements track closely with symptom improvement.
Newer treatments reinforce this picture. Ketamine, which works through an entirely different brain pathway than SSRIs, triggers rapid formation of new nerve connections in the prefrontal cortex. Its mood-altering effects wear off within about an hour, but the structural brain changes persist for a week or more, and those lasting physical changes correlate with its sustained antidepressant effects. This suggests antidepressants of various kinds work not by correcting a chemical shortage but by helping the brain physically rebuild connections that stress and depression have degraded.
Why the Framing Matters
The “chemical imbalance” explanation wasn’t just scientifically incomplete. It may have backfired in ways nobody intended. A meta-analysis of studies on how biological explanations affect public attitudes found that telling people mental illness is a brain disease or chemical imbalance did not reduce blame toward people with mental health conditions. It did, however, make people view those with mental illness as more dangerous, less likely to recover, and more deserving of social distance. In other words, the very framing designed to reduce stigma may have deepened it in some ways, by making mental illness seem like a permanent, fixed defect.
For the person experiencing depression, this framing can create a sense of helplessness. If your brain chemistry is simply broken, what can you do about it besides take a pill? A more accurate understanding opens the door wider. Depression involves a tangle of biology, psychology, and life circumstances, and that means there are multiple entry points for treatment.
A More Accurate Picture
Contemporary psychiatry has largely moved toward what’s called the biopsychosocial model. This framework recognizes that mental health conditions emerge from the interaction of biological vulnerabilities (genetics, brain structure, inflammation), psychological factors (personality, coping patterns, trauma history), and social circumstances (poverty, isolation, major life stressors, cultural context, social support). Stressful events can precipitate episodes. Social support can buffer against them. Individual differences in mental health are not solely due to brain chemistry.
This doesn’t mean depression is “all in your head” or that willpower can fix it. The brain changes in depression are real and measurable. Nerve cells shrink. Connections weaken. Inflammation rises. These are biological facts. But they arise from a web of causes, not from a single chemical being set to the wrong level. Treatments that work, whether medication, therapy, exercise, or social connection, likely succeed because they each address different threads of that web, helping the brain restore its capacity to adapt and recover.